Psychotropic Prescribing for Persons With Intellectual Disabilities and Other Psychiatric Disorders

被引:12
作者
Edelsohn, Gail A. [1 ]
Schuster, James M. [1 ]
Castelnovo, Kim [1 ]
Terhorst, Lauren [1 ]
Parthasarathy, Meghna [1 ]
机构
[1] Community Care Behav Hlth Org, Pittsburgh, PA USA
关键词
DEVELOPMENTAL-DISABILITIES; ANTIPSYCHOTIC MEDICATION; MENTAL-RETARDATION; PRIMARY-CARE; ADULTS; PREVALENCE; BEHAVIORS; PHARMACOTHERAPY; INDIVIDUALS; MANAGEMENT;
D O I
10.1176/appi.ps.201300029
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective: Prescribing patterns of psychotropic medication over a five-year period for Medicaid recipients (adults and children) with codiagnoses of an intellectual disability and a mental disorder were compared with patterns for those with sole mental disorder diagnoses. Methods: Each group was identified through paid behavioral health services claims. Four classes of medications (antidepressants, antipsychotics, benzodiazepines, and mood stabilizers) were examined in paid pharmacy claims. Diagnostic categories, rates of psychotropic prescription, and polypharmacy (three or more medications concurrently for 90 days or more) were compared by age group (child or adult). Results: Adults with mental disorders only (N=793 to 883; the range reflects the five study years) were prescribed antidepressants at a significantly higher rate compared with adults in the codiagnosis group (N=184 to 217). For three of the five study years, antipsychotics were prescribed to the sole-diagnosis group of adults at a significantly higher rate than to those with codiagnoses. Children in the group with codiagnoses (N=108 to141) were prescribed mood stabilizers at a significantly higher rate than the comparison group (N=638 to 728) in all five study years. Rates of antipsychotics prescribed were not statistically different between the two groups of children. Polypharmacy rates for both adults and children were higher for the codiagnosis group compared with the group with a sole mental disorder, but the difference did not reach statistical significance. Conclusions: Psychotropic prescribing patterns in the two groups studied varied by class of medication and age. Although evidence exists for using psychotropics to treat psychopathology and challenging behaviors among individuals with intellectual disabilities, consideration of behavioral intervention alternatives and careful monitoring of psychotropic effectiveness and side effects are recommended.
引用
收藏
页码:201 / 207
页数:7
相关论文
共 50 条
  • [21] Pharmacist interventions for persons with intellectual disabilities: A scoping review
    Lee, Catherine
    Ivo, Jessica
    Carter, Caitlin
    Faisal, Sadaf
    Shao, Yi Wen
    Patel, Tejal
    RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2021, 17 (02) : 257 - 272
  • [22] Psychotropic medications use and side effects of individuals with intellectual and developmental disabilities
    Charlot, L. R.
    Doerfler, L. A.
    McLaren, J. L.
    JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, 2020, 64 (11) : 852 - 863
  • [23] Comorbidity among persons with intellectual disabilities
    Matson, Johnny L.
    Cervantes, Paige E.
    RESEARCH IN AUTISM SPECTRUM DISORDERS, 2013, 7 (11) : 1318 - 1322
  • [24] Psychotropic medication prescribing in people with autism spectrum disorders with and without psychiatric comorbidity
    Carthy, Elliott
    Ross, Callum
    Murphy, David
    BJPSYCH ADVANCES, 2023, 29 (02) : 131 - 140
  • [25] Vision assessment in persons with intellectual disabilities
    Eisenbarth, Werner
    CLINICAL AND EXPERIMENTAL OPTOMETRY, 2018, 101 (02) : 267 - 271
  • [26] Treatment of Psychopathology in People With Intellectual and Other Disabilities
    Sturmey, Peter
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2012, 57 (10): : 593 - 600
  • [27] Prescribing patterns of psychotropic medications in psychiatric disorders: a descriptive study from Palestine
    Hattab, Suhaib
    Qasarweh, Layth
    Ahmaro, Malek
    Atatre, Yazid
    Tayem, Yasin
    Ali, Mazen
    Jahrami, Haitham
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2021, 43 (04) : 1101 - 1108
  • [28] Psychotropic Use Among Youths With Intellectual and Developmental Disabilities
    McLaren, Jennifer L.
    Lichtenstein, Jonathan D.
    Metcalfe, Justin D.
    Charlot, Lauren R.
    Drake, Robert E.
    Beasley, Joan B.
    PSYCHIATRIC SERVICES, 2021, 72 (09) : 988 - 997
  • [29] Non-psychiatric health problems among psychiatric inpatients with intellectual disabilities
    Charlot, L.
    Abend, S.
    Ravin, P.
    Mastis, K.
    Hunt, A.
    Deutsch, C.
    JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, 2011, 55 : 199 - 209
  • [30] Age-friendly communities for older persons with intellectual disabilities
    Miskimmin, Caley
    Shooshtari, Shahin
    Menec, Verena
    Duncan, Karen A.
    Martin, Toby
    Stoesz, Brenda M.
    QUALITY IN AGEING AND OLDER ADULTS, 2019, 20 (04): : 206 - 218